Developing Covid-19 Vaccines at Pandemic Speed

被引：994

作者：

Lurie, Nicole ^{[1
]}

Saville, Melanie ^{[1
]}

Hatchett, Richard ^{[1
]}

Halton, Jane ^{[1
]}

机构：

[1] Coalit Epidem Preparedness Innovat, Oslo, Norway

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2020年 / 382卷 / 21期

基金：

英国惠康基金;

关键词：

D O I：

10.1056/NEJMp2005630

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

An ideal vaccine platform would support development from viral sequencing to clinical trials in less than 16 weeks, demonstrate elicitation of consistent immune responses across pathogens, and be suitable for large-scale manufacturing using a pathogen-agnostic platform.

引用

页码：1969 / 1973

页数：5

共 5 条

[1] Estimating the cost of vaccine development against epidemic infectious diseases: a cost minimisation study [J].

Gouglas, Dimitrios ;

Tung Thanh Le ;

Henderson, Klara ;

Kaloudis, Aristidis ;

Danielsen, Trygve ;

Hammersland, Nicholas Caspersen ;

Robinson, James M. ;

Heaton, Penny M. ;

Rottingen, John-Arne .

LANCET GLOBAL HEALTH, 2018, 6 (12) :E1386-E1396

[2] The Critical Role of Biomedical Research in Pandemic Preparedness [J].

Marston, Hilary D. ;

Paules, Catharine I. ;

Fauci, Anthony S. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (18) :1757-1758

[3]

National Academies of Sciences Engineering and Medicine, 2017, INT CLIN RES EP RESP

[4]

WHO, 2020, A coordinated global research roadmap: 2019 novel coronavirus

[5]

World Health Organization, 2020, DRAFT LANDSC COVID 1

← 1 →